Intas Pharma Partners with mAbxience to Revolutionize Autoimmune Disease Treatment Landscape
Intas Pharmaceuticals announced a licensing agreement with Spanish biopharma company mAbxience for the marketing and distribution of biosimilar Etanercept. This ...
